
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting the NLRP3 Inflammasome in Severe COVID-19
Tracey Freeman, Talia H. Swartz
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 387
Tracey Freeman, Talia H. Swartz
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 387
Showing 1-25 of 387 citing articles:
Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections
Petra Zimmermann, Nigel Curtis
Archives of Disease in Childhood (2020) Vol. 106, Iss. 5, pp. 429-439
Open Access | Times Cited: 496
Petra Zimmermann, Nigel Curtis
Archives of Disease in Childhood (2020) Vol. 106, Iss. 5, pp. 429-439
Open Access | Times Cited: 496
The signal pathways and treatment of cytokine storm in COVID-19
Lan Yang, Xueru Xie, Zikun Tu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 496
Lan Yang, Xueru Xie, Zikun Tu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 496
Role of pyroptosis in inflammation and cancer
Wei Xiang, Feng Xie, Xiaoxue Zhou, et al.
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 9, pp. 971-992
Open Access | Times Cited: 369
Wei Xiang, Feng Xie, Xiaoxue Zhou, et al.
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 9, pp. 971-992
Open Access | Times Cited: 369
Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches
Yuefei Jin, Wangquan Ji, Haiyan Yang, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 364
Yuefei Jin, Wangquan Ji, Haiyan Yang, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 364
Lessons from the host defences of bats, a unique viral reservoir
Aaron T. Irving, Matae Ahn, Geraldine Goh, et al.
Nature (2021) Vol. 589, Iss. 7842, pp. 363-370
Open Access | Times Cited: 314
Aaron T. Irving, Matae Ahn, Geraldine Goh, et al.
Nature (2021) Vol. 589, Iss. 7842, pp. 363-370
Open Access | Times Cited: 314
Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities
Laura A. Bienvenu, Jonathan Noonan, Xiaowei Wang, et al.
Cardiovascular Research (2020) Vol. 116, Iss. 14, pp. 2197-2206
Open Access | Times Cited: 303
Laura A. Bienvenu, Jonathan Noonan, Xiaowei Wang, et al.
Cardiovascular Research (2020) Vol. 116, Iss. 14, pp. 2197-2206
Open Access | Times Cited: 303
Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation
Hongxu Xian, Yuan Liu, A. Nilsson, et al.
Immunity (2021) Vol. 54, Iss. 7, pp. 1463-1477.e11
Open Access | Times Cited: 267
Hongxu Xian, Yuan Liu, A. Nilsson, et al.
Immunity (2021) Vol. 54, Iss. 7, pp. 1463-1477.e11
Open Access | Times Cited: 267
Mitochondria as a Cellular Hub in Infection and Inflammation
Pauline Andrieux, Christophe Chevillard, Edécio Cunha‐Neto, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11338-11338
Open Access | Times Cited: 210
Pauline Andrieux, Christophe Chevillard, Edécio Cunha‐Neto, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11338-11338
Open Access | Times Cited: 210
Genetics Insight for COVID-19 Susceptibility and Severity: A Review
Ingrid Fricke-Galindo, Ramcés Falfán‐Valencia
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 180
Ingrid Fricke-Galindo, Ramcés Falfán‐Valencia
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 180
A Bibliometric Analysis of Pyroptosis From 2001 to 2021
Dan Ma, Bin Yang, Baoyi Guan, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 168
Dan Ma, Bin Yang, Baoyi Guan, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 168
Neutrophils and COVID-19: The road so far
Luiz Henrique Agra Cavalcante‐Silva, Deyse Cristina Madruga Carvalho, Éssia de Almeida Lima, et al.
International Immunopharmacology (2020) Vol. 90, pp. 107233-107233
Open Access | Times Cited: 161
Luiz Henrique Agra Cavalcante‐Silva, Deyse Cristina Madruga Carvalho, Éssia de Almeida Lima, et al.
International Immunopharmacology (2020) Vol. 90, pp. 107233-107233
Open Access | Times Cited: 161
Multisystem Inflammatory Syndrome in Children (MIS-C), a Post-viral Myocarditis and Systemic Vasculitis—A Critical Review of Its Pathogenesis and Treatment
Jeremy C. McMurray, Joseph W. May, Madeleine W. Cunningham, et al.
Frontiers in Pediatrics (2020) Vol. 8
Open Access | Times Cited: 157
Jeremy C. McMurray, Joseph W. May, Madeleine W. Cunningham, et al.
Frontiers in Pediatrics (2020) Vol. 8
Open Access | Times Cited: 157
Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CLpro and PLpro), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2)
Chaima Mouffouk, Soumia Mouffouk, Sara Mouffouk, et al.
European Journal of Pharmacology (2020) Vol. 891, pp. 173759-173759
Open Access | Times Cited: 151
Chaima Mouffouk, Soumia Mouffouk, Sara Mouffouk, et al.
European Journal of Pharmacology (2020) Vol. 891, pp. 173759-173759
Open Access | Times Cited: 151
Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome
Olga Sukocheva, Rebekah Maksoud, Narasimha M. Beeraka, et al.
Journal of Advanced Research (2021) Vol. 40, pp. 179-196
Open Access | Times Cited: 139
Olga Sukocheva, Rebekah Maksoud, Narasimha M. Beeraka, et al.
Journal of Advanced Research (2021) Vol. 40, pp. 179-196
Open Access | Times Cited: 139
SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway
Huanzhou Xu, Ibukun A. Akinyemi, Siddhi Chitre, et al.
Virology (2022) Vol. 568, pp. 13-22
Open Access | Times Cited: 131
Huanzhou Xu, Ibukun A. Akinyemi, Siddhi Chitre, et al.
Virology (2022) Vol. 568, pp. 13-22
Open Access | Times Cited: 131
The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies
Ni Zhao, Bin Di, Lili Xu
Cytokine & Growth Factor Reviews (2021) Vol. 61, pp. 2-15
Open Access | Times Cited: 123
Ni Zhao, Bin Di, Lili Xu
Cytokine & Growth Factor Reviews (2021) Vol. 61, pp. 2-15
Open Access | Times Cited: 123
Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice
Jianxiong Zeng, Xiaochun Xie, Xiaoli Feng, et al.
EBioMedicine (2021) Vol. 75, pp. 103803-103803
Open Access | Times Cited: 110
Jianxiong Zeng, Xiaochun Xie, Xiaoli Feng, et al.
EBioMedicine (2021) Vol. 75, pp. 103803-103803
Open Access | Times Cited: 110
Understanding the Role of SARS-CoV-2 ORF3a in Viral Pathogenesis and COVID-19
Jiantao Zhang, Amara Ejikemeuwa, Volodymyr Gerzanich, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 104
Jiantao Zhang, Amara Ejikemeuwa, Volodymyr Gerzanich, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 104
Advances in mechanism and regulation of PANoptosis: Prospects in disease treatment
Peng Zhu, Zhuo-Ran Ke, Jing-Xian Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 91
Peng Zhu, Zhuo-Ran Ke, Jing-Xian Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 91
Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer’s Disease, Parkinson’s Disease, and Long-COVID through NRF2 Activation to Counteract the NLRP3 Inflammasome
Takumi Satoh, Dorit Trudler, Chang-ki Oh, et al.
Antioxidants (2022) Vol. 11, Iss. 1, pp. 124-124
Open Access | Times Cited: 89
Takumi Satoh, Dorit Trudler, Chang-ki Oh, et al.
Antioxidants (2022) Vol. 11, Iss. 1, pp. 124-124
Open Access | Times Cited: 89
Pyroptosis-induced inflammation and tissue damage
Swathy O. Vasudevan, Bharat Behl, Vijay Rathinam
Seminars in Immunology (2023) Vol. 69, pp. 101781-101781
Open Access | Times Cited: 83
Swathy O. Vasudevan, Bharat Behl, Vijay Rathinam
Seminars in Immunology (2023) Vol. 69, pp. 101781-101781
Open Access | Times Cited: 83
The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies
Hamidreza Zalpoor, Abdullatif Akbari, Azam Samei, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 79
Hamidreza Zalpoor, Abdullatif Akbari, Azam Samei, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 79
Small molecules in the treatment of COVID-19
Sibei Lei, Xiaohua Chen, Jieping Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 78
Sibei Lei, Xiaohua Chen, Jieping Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 78
Persistent Oxidative Stress and Inflammasome Activation in CD14highCD16− Monocytes From COVID-19 Patients
Silvia Lucena Lage, Eduardo P. Amaral, Kerry L. Hilligan, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 77
Silvia Lucena Lage, Eduardo P. Amaral, Kerry L. Hilligan, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 77
Resveratrol and Immune Cells: A Link to Improve Human Health
Alessio Alesci, Noemi Nicosia, Angelo Fumia, et al.
Molecules (2022) Vol. 27, Iss. 2, pp. 424-424
Open Access | Times Cited: 75
Alessio Alesci, Noemi Nicosia, Angelo Fumia, et al.
Molecules (2022) Vol. 27, Iss. 2, pp. 424-424
Open Access | Times Cited: 75